Transferable DHA-1 cephalosporinase in Escherichia coli

被引:16
作者
Giakkoupi, P
Tambic-Andrasevic, A
Vourli, S
Skrlin, J
Sestan-Crnek, S
Tzouvelekis, LS
Vatopoulos, AC
机构
[1] Natl Sch Publ Hlth, Dept Microbiol, Athens 11521, Greece
[2] Univ Zagreb, Univ Hosp Infect Dis, Zagreb, Croatia
[3] Univ Zagreb, Univ Hosp Dubrava, Zagreb, Croatia
[4] Univ Athens, Sch Med, Dept Microbiol, GR-11527 Athens, Greece
关键词
DHA-1; cephalosporinase; Escherichia coli; Croatia;
D O I
10.1016/j.ijantimicag.2005.09.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Three Escherichia coli isolates resistant to third-generation cephalosporins but negative for extended-spectrum P-lactamase production were isolated from hospitalised patients in Zagreb, Croatia, during June 2003 to February 2004. Resistance was due to the inducible production of a DHA-1 cephalosporinase. Each isolate contained an integron-associated bla(DHA-1)-ampR sequence carried by similar-sized plasmids, of which one was self-transferable. Serotyping and polymerase chain reaction typing using ERIC2 primer indicated that the isolates were distinct. This is the first description of DHA beta-lactamase production in E. coli. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 15 条
[1]   Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States [J].
Alvarez, M ;
Tran, JH ;
Chow, N ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :533-537
[2]   Plasmid-mediated and inducible cephalosporinase DHA-2 from Klebsiella pneumoniae [J].
Fortineau, N ;
Poirel, L ;
Nordmann, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (02) :207-210
[3]   Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis [J].
Gaillot, O ;
Clement, C ;
Simonet, M ;
Philippon, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (01) :85-87
[4]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[5]  
Kim JY, 2004, ANN CLIN LAB SCI, V34, P214
[6]   First report of Salmonella isolates with the DHA-1 AmpC β-lactamase in the United Kingdom [J].
Liebana, E ;
Batchelor, M ;
Clifton-Hadley, FA ;
Davies, RH ;
Hopkins, KL ;
Threlfall, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4492-4492
[7]   Detection of β-lactamase-mediated resistance [J].
Livermore, DM ;
Brown, DFJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :59-64
[8]   CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid [J].
Miriagou, V ;
Tzouvelekis, LS ;
Villa, L ;
Lebessi, E ;
Vatopoulos, AC ;
Carattoli, A ;
Tzelepi, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) :3172-3174
[9]   Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 US hospitals [J].
Moland, ES ;
Black, JA ;
Ourada, J ;
Reisbig, MD ;
Hanson, ND ;
Thomson, KS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3837-3842
[10]   Plasmid-determined AmpC-type β-lactamases [J].
Philippon, A ;
Arlet, G ;
Jacoby, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :1-11